Riskpilot← Back to searchSign inGet full accessDeoDoc AB
ABActiveOrg 5569272171Surbrunnsgatan 26Manufacture of perfume and toilet preparations · NACE 2042Est. 20135-9 employees
Revenue 2025
SEK 31,9M
+11% vs 2024
EBITDA margin
5.7%
-63% vs 2024
Equity ratio
36.5%
Financial strength
Net profit 2025
SEK 1,4M
-45% vs 2024
| Revenue | SEK 31,9M | +11% |
| EBITDA | SEK 1,8M | -63% |
| Net profit | SEK 1,4M | -45% |
| Total assets | SEK 17,6M | +10% |
| Equity | SEK 6,4M | +28% |
| Employees | — | — |
Legal name
DeoDoc AB
Org number
5569272171
Legal form
Aktiebolag
NACE code
2042 · Manufacture of perfume and toilet preparations
Founded
28 mars 2013
Share capital
SEK 61 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska bedriva produktutveckling samt försäljning av kosmetiska produkter.
Address
Surbrunnsgatan 26
Email
hengameh@deodoc.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 5 588 | 10 474 | 17 452 | 28 689 | 19 249 | 19 777 | 28 651 | 31 945 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 478 | −59 | 275 | 808 | 2 860 | 558 | 289 | 153 | 4 826 | 1 807 |
| Depreciation & amort. | −69 | −65 | −67 | −123 | −65 | −77 | −97 | −84 | −107 | −72 |
| EBIT | 409 | −124 | 208 | 685 | 2 795 | 481 | 192 | 69 | 4 719 | 1 735 |
| Net financials | −18 | — | 57 | −102 | −28 | −4 | −137 | −32 | −375 | 713 |
| Profit before tax | 391 | −124 | 264 | 581 | 2 044 | 359 | 31 | 38 | 3 211 | 1 793 |
| Tax | −0 | −0 | −58 | −102 | −480 | −76 | −15 | −8 | −702 | −407 |
| Net profit | 391 | −124 | 206 | 479 | 1 564 | 283 | 16 | 30 | 2 509 | 1 386 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 809 | 2 255 | 3 864 | 5 547 | 9 544 | 8 977 | 13 643 | 13 694 | 16 026 | 17 580 |
| Equity | 819 | 605 | 811 | 923 | 2 487 | 2 369 | 2 385 | 2 514 | 5 023 | 6 409 |
| Long-term debt | 0 | 0 | 92 | 1 000 | 500 | 0 | 3 542 | 1 708 | 1 764 | 2 500 |
| Short-term debt | 990 | 1 650 | 2 961 | 3 624 | 5 834 | 5 765 | 6 851 | 8 606 | 7 241 | 6 015 |
| Total debt | 990 | 1 650 | 3 053 | 4 624 | 6 334 | 5 765 | 10 393 | 10 314 | 9 005 | 8 515 |
EBITDA margin
5.7%
This company
15.8%
Market median
-64% vs market
20162025
Equity ratio
36.5%
This company
38.2%
Market median
+4% vs market
20162025
Return on equity
21.6%
This company
18.4%
Market median
+17% vs market
20162025
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20162025
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
20162025
Debt / equity
1.74×
This company
0.62×
Market median
-181% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-05-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-06-01 – 2020-05-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-06-01 – 2019-05-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-06-01 – 2018-05-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-06-01 – 2017-05-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-06-01 – 2016-05-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VP Chief Auditor | Chief Auditor | 2022 | — | — |
HH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DeoDoc AB (this company)
DEODOC INCDeodoc IncBoard members of DeoDoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Victor Per Ludwig Lindhall | Chief Auditor | 0 companies |
| Hasti Heed | Chief Executive Officer | 0 companies |
| Daniel Mengescha Jontén | Board of Directors | 0 companies |
| Gunvor Ester Ekman Ordeberg | Board of Directors | 0 companies |
| John Douglas Teodor Heed | Board of Directors | 0 companies |
| Johan David Alexander Bäcke | Chairman | 0 companies |
| Pär Erik Lindell | Board of Directors | 0 companies |
| Hedieh Asadi | Board of Directors | 0 companies |
| Frans Gunnar Rickard Lyko | Board of Directors | 0 companies |